Physician profile
Eric Paul Liben
NPI 1336183888
$2,044.23
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $807 · 2020: $730 · 2021: $507.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $239.70 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $229.98 | 2019-2021 | |
| Lilly USA, LLC | $205.67 | 2019-2021 | |
| Astellas Pharma US INC | $205.54 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $198.73 | 2019-2020 | |
| Novo Nordisk INC | $129.13 | 2019-2021 | |
| Abbvie INC. | $108.10 | 2021 | |
| Merck Sharp & Dohme LLC | $104.58 | 2019-2021 | |
| Medtronic Vascular, INC. | $100.26 | 2019 | |
| Janssen Pharmaceuticals, INC | $95.81 | 2019-2021 | |
| Allergan, INC. | $75.25 | 2019-2020 | |
| Eisai INC. | $70.59 | 2020-2021 | |
| Glaxosmithkline, LLC. | $59.33 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $45.91 | 2019-2020 | |
| Amgen INC. | $41.87 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $24.64 | 2019 | |
| Scilex Pharmaceuticals INC. | $23.80 | 2020 | |
| Abbott Laboratories | $23.24 | 2019 | |
| Nestle Healthcare Nutrition INC. | $22.32 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.13 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.65 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Liben listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.